Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250610649423/en/shibio-Doses-First-Patient-in-Phase-1b-Trial-of-Andecaliximab-in-Patients-with-Spinal-Cord-Injury-SCI-at-Risk-of-Heterotopic-Ossification-HO

BUSINESSWIRE
24 Jun 2025

https://www.businesswire.com/news/home/20250123107374/en

BUSINESSWIRE
23 Jan 2025